Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration

(1) Background: The aim of the present pilot study was to study the effect of a new oral gonadotropin-releasing hormone antagonist on adenomyosis. (2) Methods: Eight premenopausal women, aged between 37 and 45 years, presenting with heavy menstrual bleeding, pelvic pain, and dysmenorrhea due to diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Donnez, Jacques, Donnez, Olivier, Tourniaire, Jean, Brethous, Michel, Bestel, Elke, Garner, Elizabeth, Charpentier, Sébastien, Humberstone, Andrew, Loumaye, Ernest
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706704/
https://www.ncbi.nlm.nih.gov/pubmed/34945090
http://dx.doi.org/10.3390/jcm10245794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706704/
https://www.ncbi.nlm.nih.gov/pubmed/34945090
http://dx.doi.org/10.3390/jcm10245794

Ejemplares similares